Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

(PV) treatment approaches include both therapeutic phlebotomy and medications like hydroxyurea or interferon to control blood counts, with treatment selection based on individual risk factors and ...

Findings show that 81% of posts related to cancer on the social media platform TikTok touted fake cures. Most cancer cures ...

I share how faith, positive affirmations and resilience helped me overcome stage 2 colon cancer and find strength in recovery ...

Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others ...

The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.

Subcutaneous Sarclisa, administered via OBDS, showed non-inferior efficacy to IV Sarclisa in relapsed/refractory multiple ...

Obtaining a second opinion during your cancer treatment can be a daunting but also life-changing step; however, surprisingly ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.